CHRS

SEC source: 0001610717-25-000223 · form4.xml · derivative · entry 1

Newton Charles W. · CIK 0001866219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-25-000227 · form4.xml · derivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-25-000229 · form4.xml · derivative · entry 1

O'Donnell-Tormey Jill · CIK 0001927733 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-25-000228 · form4.xml · derivative · entry 1

Newcomer Lee Nisley · CIK 0001788981 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-25-000226 · form4.xml · derivative · entry 1

Ryan Michael Lee · CIK 0001985918 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-25-000225 · form4.xml · derivative · entry 1

Karachun Rita A · CIK 0001601572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-25-000224 · form4.xml · derivative · entry 1

Erbez Georgia · CIK 0001557930 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-25-000222 · form4.xml · derivative · entry 1

Satvat Ali J. · CIK 0001621788 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-25-000145 · form4.xml · nonDerivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Leonard Capital, LLC

Disclosed balance after: 0

F1 · kind: The reported sale transactions were effected for tax planning purposes.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7362 to $0.7448, exclusive of any fees, commissions or other expenses. The Reporting Person undertakes to provide to Coherus BioSciences, Inc., any security holder of Coherus BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: The Reporting Person and his spouse are the members of Leonard Capital, LLC and therefore the Reporting Person may be deemed to have voting and dispositive power of shares held by Leonard Capital, LLC.

SEC source: 0001610717-25-000116 · form4.xml · derivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375,000

Underlying: Common Stock · 375,000 shares

Expires 2035-05-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of May 7, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-25-000117 · form4.xml · derivative · entry 1

McMichael Bryan J · CIK 0001944868 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2035-05-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of May 7, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-25-000013 · form4.xml · nonDerivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 685,074

F1 · shares: Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.

SEC source: 0001610717-25-000015 · form4.xml · nonDerivative · entry 1

McMichael Bryan J · CIK 0001944868 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,951

F1 · shares: Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.

SEC source: 0001610717-25-000014 · form4.xml · nonDerivative · entry 1

Reider Paul · CIK 0001970033 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,069

F1 · shares: Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.

SEC source: 0001610717-25-000011 · form4.xml · derivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 575,000

Underlying: Common Stock · 575,000 shares

Expires 2035-01-10

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 10, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-25-000010 · form4.xml · nonDerivative · entry 1

McMichael Bryan J · CIK 0001944868 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,662

F1 · shares: Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.

F2 · balance_after: Includes 3,401 shares acquired on May 15, 2023 pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan.

SEC source: 0001610717-25-000009 · form4.xml · nonDerivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 696,884

F1 · shares: Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.

SEC source: 0001610717-25-000007 · form4.xml · nonDerivative · entry 1

Reider Paul · CIK 0001970033 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,927

F1 · shares: Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.

SEC source: 0001610717-25-000008 · form4.xml · derivative · entry 1

McMichael Bryan J · CIK 0001944868 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2035-01-03

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 3, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-25-000007 · form4.xml · derivative · entry 2

Reider Paul · CIK 0001970033 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2035-01-03

F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 3, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-24-000542 · form4.xml · nonDerivative · entry 1

Reider Paul · CIK 0001970033 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,204

F1 · shares: Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.

F2 · balance_after: Includes 5,000 shares acquired on November 15, 2024 and 5,000 shares acquired on May 15, 2024, each pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan.

SEC source: 0001610717-24-000424 · form4.xml · derivative · entry 1

McMichael Bryan J · CIK 0001944868 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2034-08-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of August 1, 2024 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-24-000406 · form4.xml · derivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,500

Underlying: Common Stock · 196,500 shares

Expires 2034-04-11

F1 · derivative.exercise_date: On April 11, 2024 the Reporting Person was granted a performance stock option to purchase 982,500 shares of common stock, of which 196,500 of the shares vested and became exercisable on July 22, 2024 in connection with the Closing of the sale of Coherus BioSciences, Inc.'s YUSIMRY franchise.

SEC source: 0001610717-24-000405 · form4.xml · derivative · entry 1

Reider Paul · CIK 0001970033 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2034-04-11

F1 · derivative.exercise_date: On April 11, 2024 the Reporting Person was granted a performance stock option to purchase 200,000 shares of common stock, of which 40,000 of the shares vested and became exercisable on July 22, 2024 in connection with the Closing of the sale of Coherus BioSciences, Inc.'s YUSIMRY franchise.

SEC source: 0001610717-24-000295 · form4.xml · derivative · entry 1

Karachun Rita A · CIK 0001601572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,000

Underlying: Common Stock · 168,000 shares

Expires 2034-06-04

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/3rd of the total number of shares on the one year anniversary of June 4, 2024 and 1/36th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-24-000293 · form4.xml · derivative · entry 1

Erbez Georgia · CIK 0001557930 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,000

Underlying: Common Stock · 114,000 shares

Expires 2034-06-04

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/3rd of the total number of shares on the one year anniversary of June 4, 2024 and 1/36th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-24-000292 · form4.xml · derivative · entry 1

Newton Charles W. · CIK 0001866219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2034-06-03

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-24-000290 · form4.xml · derivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2034-06-03

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-24-000289 · form4.xml · derivative · entry 1

STOLPER MARK · CIK 0001281961 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2034-06-03

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-24-000291 · form4.xml · derivative · entry 1

Ryan Michael Lee · CIK 0001985918 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2034-06-03

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-24-000288 · form4.xml · derivative · entry 1

Newcomer Lee Nisley · CIK 0001788981 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2034-06-03

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-24-000287 · form4.xml · derivative · entry 1

TZOUMAKAS KIMBERLY JO · CIK 0001766666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2034-06-03

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-24-000286 · form4.xml · derivative · entry 1

O'Donnell-Tormey Jill · CIK 0001927733 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2034-06-03

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.

SEC source: 0001610717-24-000088 · form4.xml · derivative · entry 1

Erbez Georgia · CIK 0001557930 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,000

Underlying: Common Stock · 54,000 shares

Expires 2034-02-20

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from February 20, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-24-000060 · form4.xml · nonDerivative · entry 2

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Leonard Capital, LLC

Disclosed balance after: 99,988

F1 · kind: Reflects the transfer, for no consideration, of 99,988 shares directly owned by the Reporting Person to Leonard Capital, LLC.

F2 · ownership.nature: The Reporting Person and his spouse are the members of Leonard Capital, LLC and therefore the Reporting Person may be deemed to have voting and dispositive power of shares held by Leonard Capital, LLC.

SEC source: 0001610717-24-000060 · form4.xml · nonDerivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Reflects the transfer, for no consideration, of 99,988 shares directly owned by the Reporting Person to Leonard Capital, LLC.

SEC source: 0001610717-24-000044 · form4.xml · derivative · entry 4

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 44,991 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001610717-24-000044 · form4.xml · derivative · entry 3

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,997 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001610717-24-000044 · form4.xml · nonDerivative · entry 2

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,988

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price.

SEC source: 0001610717-24-000044 · form4.xml · nonDerivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,997

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price.

SEC source: 0001610717-24-000039 · form4.xml · nonDerivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 708,694

F1 · shares: Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.

SEC source: 0001610717-24-000038 · form4.xml · nonDerivative · entry 1

Reider Paul · CIK 0001970033 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,277

F1 · shares: Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.

SEC source: 0001610717-24-000037 · form4.xml · nonDerivative · entry 1

McMichael Bryan J · CIK 0001944868 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,972

F1 · shares: Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.

SEC source: 0001610717-24-000023 · form4.xml · nonDerivative · entry 1

McMichael Bryan J · CIK 0001944868 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,679

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

SEC source: 0001610717-24-000019 · form4.xml · derivative · entry 4

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 575,000

Underlying: Common Stock · 575,000 shares

Expires 2034-01-05

F4 · derivative.exercise_date: 1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 5, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-24-000019 · form4.xml · nonDerivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 719,912

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

SEC source: 0001610717-24-000018 · form4.xml · nonDerivative · entry 1

Reider Paul · CIK 0001970033 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,131

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

SEC source: 0001610717-24-000012 · form4.xml · derivative · entry 1

McMichael Bryan J · CIK 0001944868 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-01-02

F1 · derivative.exercise_date: 1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 2, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-24-000011 · form4.xml · derivative · entry 1

Reider Paul · CIK 0001970033 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2034-01-02

F1 · derivative.exercise_date: 1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 2, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-24-000001 · form4.xml · nonDerivative · entry 1

Stilwell McDavid · CIK 0001851389 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,305

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

F2 · balance_after: Includes 4,826 shares acquired on November 15, 2023, pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan and includes the cancellation of 13,333 restricted stock units.